Unique ID issued by UMIN | UMIN000022085 |
---|---|
Receipt number | R000025465 |
Scientific Title | The verification study of the anti-obesity effect in healthy Japanese adults: a double-blind randomized, parallel-group, controlled trial |
Date of disclosure of the study information | 2016/04/26 |
Last modified on | 2017/01/30 18:48:48 |
The verification study of the anti-obesity effect in healthy Japanese adults: a double-blind randomized, parallel-group, controlled trial
The verification study of the anti-obesity effect in healthy Japanese adults
The verification study of the anti-obesity effect in healthy Japanese adults: a double-blind randomized, parallel-group, controlled trial
The verification study of the anti-obesity effect in healthy Japanese adults
Japan |
Healthy adults
Not applicable | Adult |
Others
NO
To verify the anti-obesity effect due to the ingestion of the test food
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
1. Total fat area
2. Subcutaneous fat area
3. Visceral fat area
*Measuring point: at 0 week, 4 weeks, 8 weeks and 12 weeks after ingestion
Weight
Body Mass Index (BMI)
Body fat percentage
Waist Circumference
Adiponectin
Total cholesterol
HDL cholesterol
LDL cholesterol
Triglyceride
Free fatty acid
Questionnaire (Likert scale)
*Measuring point: at 0 week, 4 weeks, 8 weeks and 12 weeks after ingestion
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
NO
NO
Institution is not considered as adjustment factor.
NO
No need to know
2
Treatment
Food |
Duration: 12 weeks
Test material: Angelica keiskei powder
Dose: 2 packs a day
Administration: Dissolve the test food in water or warm water, and ingested at any time
Duration: 12 weeks
Test material: Placebo powder
Dose: 2 packs a day
Administration: Dissolve the test food in water or warm water, and ingested at any time
20 | years-old | <= |
Not applicable |
Male and Female
1. Healthy Japanese adults
2. BMI (25 kg/m2 to less than 30 kg/m2)
1. At least one previous medical history of malignant tumor, heart failure or myocardial infarction
2. Currently under the treatment for either atrial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases
3. Currently taking medicines (include herbal medicines), and/or supplements
4. Allergic to medicines or foods related to the test food of this trial
5. Pregnant, lactating, or planning to get pregnant during the trial period
6. Enrolled into other clinical trials within the last 3 months before agreeing to participate in this trial
7. Judged unsuitable for participating in this trial by physician
60
1st name | |
Middle name | |
Last name | Kazuo YAMAMOTO |
ORTHOMEDICO, Inc.
R&D Department
2F Sumitomo Fudosan Korakuen Bldg., 1-4-1 Koishikawa, Bunkyo-ku, Tokyo.
03-3818-0610
kazu@orthomedico.jp
1st name | |
Middle name | |
Last name | Naoko SUZUKI |
ORTHOMEDICO, Inc.
R&D Department
2F Sumitomo Fudosan Korakuen Bldg., 1-4-1 Koishikawa, Bunkyo-ku, Tokyo.
03-3818-0610
nao@orthomedico.jp
ORTHOMEDICO, Inc.
TAKARA BIO INC.
Profit organization
Seishin-kai Medical Association Inc, Takara Medical Clinic.
NO
2016 | Year | 04 | Month | 26 | Day |
Unpublished
Completed
2016 | Year | 04 | Month | 18 | Day |
2016 | Year | 04 | Month | 27 | Day |
2016 | Year | 11 | Month | 20 | Day |
2016 | Year | 11 | Month | 30 | Day |
2016 | Year | 11 | Month | 30 | Day |
2016 | Year | 12 | Month | 28 | Day |
2016 | Year | 04 | Month | 26 | Day |
2017 | Year | 01 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025465